Vabysmo Umoja wa Ulaya - Kiaisilandi - EMA (European Medicines Agency)

vabysmo

roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - augnlækningar - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).

Anafranil Húðuð tafla 25 mg Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

anafranil húðuð tafla 25 mg

pharmaand gmbh - clomipraminum hýdróklóríð - húðuð tafla - 25 mg

Kalmente Nefúði, dreifa 50 míkróg/skammt Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

kalmente nefúði, dreifa 50 míkróg/skammt

zentiva k.s.* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt

Livostin Nefúði, dreifa 0,5 mg/ml Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

livostin nefúði, dreifa 0,5 mg/ml

mcneil sweden ab - levocabastinum hýdróklóríð - nefúði, dreifa - 0,5 mg/ml

Nasonex Nefúði, dreifa 50 míkróg/skammt Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

nasonex nefúði, dreifa 50 míkróg/skammt

n.v. organon* - mometasonum fúróat - nefúði, dreifa - 50 míkróg/skammt

Nasacort Nefúði, dreifa 55 míkróg/skammt Aislandi - Kiaisilandi - LYFJASTOFNUN (Icelandic Medicines Agency)

nasacort nefúði, dreifa 55 míkróg/skammt

opella healthcare france s.a.s. - triamcinolonum acetóníð - nefúði, dreifa - 55 míkróg/skammt